Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANVS
#3492
Annovis Bio, Inc.
2.6
9
-2.54%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-2.54%
Monthly Change
-9.12%
6 month change
+14.47%
Cambio anual
+46.20%
Cierres anteriores
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Volumen
28
Markets
Acciones
Atención Sanitaria
ANVS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
-3.97 M
-9.13 M
-17.31 M
-39.97 M
-21.89 M
-24.98 M
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
12.04 M
46.74 M
4 613
17.34 M
26.69 M
27.63 M
Free cash flow
-3.97 M
-9.13 M
-17.31 M
-39.97 M
-21.89 M
-24.98 M
Noticias
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Director de Annovis Bio, Hoffman, compra acciones por $193,794
Director de Annovis Bio, Hoffman, compra acciones por 193.794 dólares
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Director de Annovis Bio, Hoffman, compra $69.9k en acciones de ANVS
El director de Annovis Bio, Hoffman, compra acciones de ANVS por 69.900 dólares
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Director de Annovis Bio compra acciones por $31,649
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)